FutureChem Co Ltd
KOSDAQ:220100
Intrinsic Value
FutureChem Co., Ltd. engages in the manufacture of medical products. [ Read More ]
The intrinsic value of one FutureChem Co Ltd stock under the Base Case scenario is 1 388.95 KRW. Compared to the current market price of 13 500 KRW, FutureChem Co Ltd is Overvalued by 90%.
Valuation Backtest
FutureChem Co Ltd
Run backtest to discover the historical profit from buying and selling FutureChem Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
FutureChem Co Ltd
Current Assets | 32B |
Cash & Short-Term Investments | 25.8B |
Receivables | 3.7B |
Other Current Assets | 2.5B |
Non-Current Assets | 40.8B |
Long-Term Investments | 938.3m |
PP&E | 32.6B |
Intangibles | 4B |
Other Non-Current Assets | 3.3B |
Current Liabilities | 3.6B |
Accounts Payable | 297.3m |
Accrued Liabilities | 1.3B |
Other Current Liabilities | 2.1B |
Non-Current Liabilities | 5.4B |
Long-Term Debt | 2.6B |
Other Non-Current Liabilities | 2.8B |
Earnings Waterfall
FutureChem Co Ltd
Revenue
|
14B
KRW
|
Cost of Revenue
|
-12.4B
KRW
|
Gross Profit
|
1.6B
KRW
|
Operating Expenses
|
-10B
KRW
|
Operating Income
|
-8.4B
KRW
|
Other Expenses
|
1.7B
KRW
|
Net Income
|
-6.7B
KRW
|
Free Cash Flow Analysis
FutureChem Co Ltd
Profitability Score
Profitability Due Diligence
FutureChem Co Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
FutureChem Co Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
FutureChem Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
FutureChem Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
FutureChem Co Ltd
Shareholder Return
Price
FutureChem Co Ltd
Average Annual Return | 19.93% |
Standard Deviation of Annual Returns | 77.42% |
Max Drawdown | -66% |
Market Capitalization | 298.3B KRW |
Shares Outstanding | 22 096 973 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.
Contact
IPO
Employees
Officers
The intrinsic value of one FutureChem Co Ltd stock under the Base Case scenario is 1 388.95 KRW.
Compared to the current market price of 13 500 KRW, FutureChem Co Ltd is Overvalued by 90%.